Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

Fig. 7

RMSD analysis of docked complex of NFATc1-BCA, ERK-BCA and JNK-BCA. (The purple line represents the change of RMSD value of NFATc1-BCA receptor-ligand complex; The orange line represents the change in RMSD of the ERK-biochanin A receptor-ligand complex; The blue line represents the RMSD changes of the JNK-BCA receptor-ligand complex; The green line represents the RMSD changes of the c-fos-BCA receptor-ligand complex)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us